Webinar | Is your natural food dye compliant, shelf-stable, and ready to scale?
24th July | 12 PM ET: Register Now
Webinar | Is your natural food dye compliant, shelf-stable, and ready to scale?
24th July | 12 PM ET: Register Now
AOMedia finalized the AV2 1.0.0 specification on May 29, 2026. A patent acquisition covering AV2 closed ten days before that finalization date. Sauvegarder Investment Management, an IP monetization firm, bought
The single most active filer in GreyB’s EPO opposition dataset, spanning 2021 to 2026 across all sectors, isn’t Teva, Sandoz, Nicoventures, or Philip Morris. It’s Strawman Limited, with 210 recorded
A licensor walks into a Cat-M1 negotiation citing 2,000 declared LTE families. The implementer across the table does not dispute the number. Instead, they ask a different question: how many
In SEP licensing, a declaration costs almost nothing, but challenging it costs a fortune. Across 5G, 4G LTE, HEVC, and Wi-Fi, rigorous independent reviews consistently show that 30% to 60%
Patent landscape analysis is a macro-level intelligence exercise that tells R&D leaders not just what is protected, but where innovation is clustering, who is driving it, and what is about
Since 2025, the U.S. patent system has moved into a period of active recalibration, with the PTAB at the center of policy, legal, and industry debate. Recent congressional discussions and
Of the 36,166 Change Requests submitted to 3GPP for 5G-Advanced, 45.6% are concentrated in the technologies most critical to 6G. Yet only 21.9% of declared SEP families cover these same
Over 100,000 patent families have been declared essential to 4G and 5G standards. A growing share of licensing campaigns built on that number are now targeting vehicle manufacturers. The shift
Seventeen high-revenue small-molecule drugs were examined beyond simple patent expiry timelines. The review incorporated regulatory protections, competitor filings, and supply arrangements, factors that often surface late in the planning cycle
As healthcare budgets across Europe remain under pressure, 2026 marks an important turning point. Multiple high-cost medicines are scheduled to lose regulatory exclusivity, enabling future price competition and expanded patient
The evolution of 5G has entered a new phase, one defined not just by faster speeds but by intelligence, adaptability, and cross-domain integration. As 5G-Advanced continues to mature through 2026,
With the IoT devices projected to surpass 24 billion by 2025, the importance of enhanced connectivity has never been more evident. This is where 6G emerges as the zenith. With
As the world transitions into the metaverse, 8K streaming, and autonomous systems, the demand for a codec more powerful than H.266/VVC is no longer a distant vision. It’s an immediate
In 2025, the FDA has approved 28 new therapies, each signaling how the next decade of pharma innovation and IP strategy will unfold. From oncology and rare diseases to quality-of-life
For over a century, Disney has captivated audiences worldwide, blending storytelling magic with technological marvel. Behind the enchanting characters and immersive experiences lies a meticulously managed intellectual property portfolio, a
The automotive industry stands at an inflection point, driven by transformative shifts towards electric vehicles, autonomous driving, and advanced connectivity. In this landscape, intellectual property (IP) has become a paramount
